Biosimilar Basics: Legislation

Update: 2024-05-23

Description

In this episode, the third of our Biosimilars series, Corey Ford, Vice President of Reimbursement and Policy Insights, and Cristina Muñoz, Senior Director of Head of State Government Advocacy discuss legislation surrounding biosimilars.

Our next episode will feature information on the biosimilar payer perspective. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

Comments

In Channel

Q3 GPO Legislative Townhall

2025-10-0935:15

Inflation Reduction Act: Current State

2025-08-1409:28

Q2 GPO Legislative Townhall

2025-07-3149:22

Inflation Reduction Act: Overview

2025-07-2215:09

505(b)(2) Operationalizing in Practice - Provider Perspective

2025-05-1320:25

505(b)(2) Operationalizing in Practice - Pharmacist Perspective

2025-05-0110:32

505(b)(2) Billing and Reimbursement

2025-04-1739:31

505(b)(2) Landscape and Pipeline

2025-04-0332:36

505(b)(2) Basics

2025-03-1830:47

Buy and Bill: Practice Perspective

2025-02-0436:48

Buy and Bill: The Basics

2025-01-2218:21

GPO 101: Legislative Townhall

2025-01-0838:12

Biosimilar Basics: Payer Perspective

2024-06-1922:41

Biosimilar Basics: Legislation

2024-05-2316:27

Biosimilar Basics: Market Landscape

2024-05-0119:26

Biosimilar Basics: Overview

2024-04-1717:47

GPO Legislative Townhall December 2023: Part 11

2024-02-0808:24

GPO Legislative Townhall December 2023: Part 10

2024-02-0815:32

GPO Legislative Townhall December 2023: Part 9

2024-01-1112:30

GPO Legislative Townhall August 2023: Part 8

2023-11-2928:24

00:00

Biosimilar Basics: Legislation

#box-pro-ellipsis-176682892809774{-webkit-line-clamp:2;}Biosimilar Basics: Legislation

Biosimilar Basics: Legislation

Cencora

Biosimilar Basics: Legislation